Kevin Cronin Clark

This profile gathers the share dealings of Kevin Cronin Clark in Cross Country Healthcare Inc, where the filings describe the role as chief executive. Between 31 March 2019 and 21 July 2026, the trades on record add up to 40 filings.

The open-market record is one-sided, with 10 purchases worth €466k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 27 share grants.

A typical purchase (the median) is worth €26k. Clusters matter here: 9 out of 10 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 21 July 2026, the filings show a share grant in Cross Country Healthcare Inc. The last insider purchase was made public on 1 September 2020, 2,245 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.